E-Book, Englisch, 312 Seiten, eBook
ISBN: 978-1-4939-0515-7
Verlag: Springer US
Format: PDF
Kopierschutz: 1 - PDF Watermark
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Weitere Infos & Material
Prevalence of dyslipidemia in general and in the CKD patient.- Lipid Nephrotoxicity: New Concept for an Old Disease.- Hyperlipidemia a risk factor or protective for progression of CKD in nondibetics.- How lipid lowering agents works: The good, the bad and the ugly.- CVD in CKD - Focus on the dyslipidemia problem.- The CKD patient with dyslipidemia.- Review of Clinical Trials pertaining to dyslipidemias in CKD.- Lifestyle modifications in the management of dyslipidemias in CKD.- Lipid-Lowering Medication Does Adjustments for Reduced Kidney Function.- Non-statins therapies for CKD with dyslipidemia.- Dyslipidemia in dialysis.- Dyslipidemia in the Kidney Transplant Patient.- Dyslipidemia in the Patient with Nephrotic syndrome.- Dyslipidemias in the Pediatric CKD Patient.- Dyslipidemias in the Geriatric CKD Patient.- Dialysis modalities in dyslipidemia.- Review of current guidelines.